---
reference_id: "PMID:28157540"
title: "Large Intragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated Spastic Paraparesis, SPG23."
authors:
- Lee JYW
- Hsu CK
- Michael M
- Nanda A
- Liu L
- McMillan JR
- Pourreyron C
- Takeichi T
- Tolar J
- Reid E
- Hayday T
- Blumen SC
- Abu-Mouch S
- Straussberg R
- Basel-Vanagaite L
- Barhum Y
- Zouabi Y
- Al-Ajmi H
- Huang HY
- Lin TC
- Akiyama M
- Lee JYY
- McLean WHI
- Simpson MA
- Parsons M
- McGrath JA
journal: Am J Hum Genet
year: '2017'
doi: 10.1016/j.ajhg.2017.01.014
content_type: abstract_only
---

# Large Intragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated Spastic Paraparesis, SPG23.
**Authors:** Lee JYW, Hsu CK, Michael M, Nanda A, Liu L, McMillan JR, Pourreyron C, Takeichi T, Tolar J, Reid E, Hayday T, Blumen SC, Abu-Mouch S, Straussberg R, Basel-Vanagaite L, Barhum Y, Zouabi Y, Al-Ajmi H, Huang HY, Lin TC, Akiyama M, Lee JYY, McLean WHI, Simpson MA, Parsons M, McGrath JA
**Journal:** Am J Hum Genet (2017)
**DOI:** [10.1016/j.ajhg.2017.01.014](https://doi.org/10.1016/j.ajhg.2017.01.014)

## Content

1. Am J Hum Genet. 2017 Feb 2;100(2):364-370. doi: 10.1016/j.ajhg.2017.01.014.

Large Intragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated 
Spastic Paraparesis, SPG23.

Lee JYW(1), Hsu CK(2), Michael M(3), Nanda A(4), Liu L(5), McMillan JR(5), 
Pourreyron C(6), Takeichi T(7), Tolar J(8), Reid E(9), Hayday T(3), Blumen 
SC(10), Abu-Mouch S(11), Straussberg R(12), Basel-Vanagaite L(13), Barhum Y(14), 
Zouabi Y(15), Al-Ajmi H(4), Huang HY(16), Lin TC(16), Akiyama M(17), Lee 
JYY(16), McLean WHI(18), Simpson MA(19), Parsons M(3), McGrath JA(20).

Author information:
(1)St John's Institute of Dermatology, King's College London (Guy's Campus), 
London SE1 9RT, UK.
(2)Department of Dermatology, National Cheng Kung University Hospital, College 
of Medicine, National Cheng Kung University, Tainan 701, Taiwan; Institute of 
Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 
701, Taiwan.
(3)Randall Division of Cell and Molecular Biophysics, King's College London 
(Guy's Campus), London SE1 9RT, UK.
(4)As'ad Al-Hamad Dermatology Center, Al-Sabah Hospital, Kuwait City 13001, 
Kuwait.
(5)The National Diagnostic EB Laboratory, Viapath, St Thomas' Hospital, London 
SE1 7EH, UK.
(6)Jacqui Wood Cancer Centre, University of Dundee, Ninewells Hospital and 
Medical School, Dundee DD1 9SY, UK.
(7)St John's Institute of Dermatology, King's College London (Guy's Campus), 
London SE1 9RT, UK; Department of Dermatology, Nagoya University Graduate School 
of Medicine, Nagoya 466-8560, Japan.
(8)Department of Pediatrics, Division of Blood and Marrow Transplantation, 
University of Minnesota, Minneapolis, MN 55455, USA; Stem Cell Institute, 
University of Minnesota, Minneapolis, MN 55455, USA.
(9)Cambridge Institute for Medical Research (CIMR), University of Cambridge, 
Cambridge CB2 0XY, UK; Department of Medical Genetics, Addenbrooke's Hospital, 
University of Cambridge, Cambridge CB2 0QQ, UK.
(10)Department of Neurology, Hillel Yaffe Medical Center, Hadera 38100, Israel; 
Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 
3525433, Israel.
(11)Liver Unit, Department of Internal Medicine B, Hillel Yaffe Medical Center, 
Hadera 38100, Israel.
(12)Neurogenetic Service, Neurology Institute, Schneider Children's Medical 
Center, Petah Tikva 49202, Israel; Sackler Faculty of Medicine, Tel Aviv 
University, Tel Aviv 69978, Israel.
(13)Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel; 
Raphael Recanati Genetic Institute, Rabin Medical Center, Beilinson Campus, 
Petah Tikva 49100, Israel; Pediatric Genetics Unit, Schneider Children's Medical 
Center, Petah Tikva 49202, Israel; Felsenstein Medical Research Center, Rabin 
Medical Center, Petah Tikva 4941492, Israel.
(14)Laboratory of Clinical Neuroscience, Felsenstein Medical Research Center, 
Rabin Medical Center, Petah Tikva 4941492, Israel; Department of Neurology, 
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
(15)Neurogenetic Service, Neurology Institute, Schneider Children's Medical 
Center, Petah Tikva 49202, Israel.
(16)Department of Dermatology, National Cheng Kung University Hospital, College 
of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
(17)Department of Dermatology, Nagoya University Graduate School of Medicine, 
Nagoya 466-8560, Japan.
(18)Centre for Dermatology and Genetic Medicine, Division of Molecular Medicine, 
University of Dundee, Dundee DD1 5EH, UK.
(19)Department of Medical and Molecular Genetics, King's College London, School 
of Medicine, Guy's Hospital, London SE1 9RT, UK.
(20)St John's Institute of Dermatology, King's College London (Guy's Campus), 
London SE1 9RT, UK; Centre for Dermatology and Genetic Medicine, Division of 
Molecular Medicine, University of Dundee, Dundee DD1 5EH, UK. Electronic 
address: john.mcgrath@kcl.ac.uk.

SPG23 is an autosomal-recessive neurodegenerative subtype of lower limb spastic 
paraparesis with additional diffuse skin and hair dyspigmentation at birth 
followed by further patchy pigment loss during childhood. Previously, 
genome-wide linkage in an Arab-Israeli pedigree mapped the gene to an 
approximately 25 cM locus on chromosome 1q24-q32. By using whole-exome 
sequencing in a further Palestinian-Jordanian SPG23 pedigree, we identified a 
complex homozygous 4-kb deletion/20-bp insertion in DSTYK (dual serine-threonine 
and tyrosine protein kinase) in all four affected family members. DSTYK is 
located within the established linkage region and we also found the same 
mutation in the previously reported pedigree and another Israeli pedigree (total 
of ten affected individuals from three different families). The mutation removes 
the last two exons and part of the 3' UTR of DSTYK. Skin biopsies revealed 
reduced DSTYK protein levels along with focal loss of melanocytes. 
Ultrastructurally, swollen mitochondria and cytoplasmic vacuoles were also noted 
in remaining melanocytes and some keratinocytes and fibroblasts. Cultured 
keratinocytes and fibroblasts from an affected individual, as well as knockdown 
of Dstyk in mouse melanocytes, keratinocytes, and fibroblasts, were associated 
with increased cell death after ultraviolet irradiation. Keratinocytes from an 
affected individual showed loss of kinase activity upon stimulation with 
fibroblast growth factor. Previously, dominant mutations in DSTYK were 
implicated in congenital urological developmental disorders, but our study 
identifies different phenotypic consequences for a recurrent autosomal-recessive 
deletion mutation in revealing the genetic basis of SPG23.

Copyright Â© 2017 American Society of Human Genetics. Published by Elsevier Inc. 
All rights reserved.

DOI: 10.1016/j.ajhg.2017.01.014
PMCID: PMC5294675
PMID: 28157540 [Indexed for MEDLINE]